Literature DB >> 17035306

Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection.

Jessica Wagoner1, Michael Austin, Jamison Green, Tadaatsu Imaizumi, Antonella Casola, Allan Brasier, Khalid S A Khabar, Takaji Wakita, Michael Gale, Stephen J Polyak.   

Abstract

Hepatitis C virus (HCV) infection induces the alpha-chemokine interleukin-8 (CXCL-8), which is regulated at the levels of transcription and mRNA stability. In the current study, CXCL-8 regulation by double-stranded (ds)RNA pathways was analyzed in the context of HCV infection. A constitutively active mutant of the retinoic acid-inducible gene I (RIG-I), RIG-N, activated CXCL-8 transcription. Promoter mutagenesis experiments indicated that NF-kappaB and interferon (IFN)-stimulated response element (ISRE) binding sites were required for the RIG-N induction of CXCL-8 transcription. IFN-beta promoter stimulator 1 (IPS-1) expression also activated CXCL-8 transcription, and mutations of the ISRE and NF-kappaB binding sites reduced and abrogated CXCL-8 transcription, respectively. In the presence of wild-type RIG-I, transfection of JFH-1 RNA or JFH-1 virus infection of Huh7.5.1 cells activated the CXCL-8 promoter. Expression of IFN regulatory factor 3 (IRF-3) stimulated transcription from both full-length and ISRE-driven CXCL-8 promoters. Chromatin immunoprecipitation assays demonstrated that IRF-3 and NF-kappaB bound directly to the CXCL-8 promoter in response to virus infection and dsRNA transfection. RIG-N stabilized CXCL-8 mRNA via the AU-rich element in the 3' untranslated region of CXCL-8 mRNA, leading to an increase in its half-life following tumor necrosis factor alpha induction. The data indicate that HCV infection triggers dsRNA signaling pathways that induce CXCL-8 via transcriptional activation and mRNA stabilization and define a regulatory link between innate antiviral and inflammatory cellular responses to virus infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035306      PMCID: PMC1797246          DOI: 10.1128/JVI.01411-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  Interferon regulatory factors: the next generation.

Authors:  Y Mamane; C Heylbroeck; P Génin; M Algarté; M J Servant; C LePage; C DeLuca; H Kwon; R Lin; J Hiscott
Journal:  Gene       Date:  1999-09-03       Impact factor: 3.688

Review 2.  The AU-rich transcriptome: more than interferons and cytokines, and its role in disease.

Authors:  Khalid S A Khabar
Journal:  J Interferon Cytokine Res       Date:  2005-01       Impact factor: 2.607

Review 3.  Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma.

Authors:  Mark Branda; Jack R Wands
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

4.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

5.  Type-specific induction of interleukin-8 by adenovirus.

Authors:  J Leland Booth; J P Metcalf
Journal:  Am J Respir Cell Mol Biol       Date:  1999-10       Impact factor: 6.914

6.  Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways.

Authors:  H Holtmann; R Winzen; P Holland; S Eickemeier; E Hoffmann; D Wallach; N L Malinin; J A Cooper; K Resch; M Kracht
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

7.  Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation.

Authors:  S Vlahopoulos; I Boldogh; A Casola; A R Brasier
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms.

Authors:  Guofeng Cheng; Jin Zhong; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-17       Impact factor: 11.205

9.  The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.

Authors:  R Winzen; M Kracht; B Ritter; A Wilhelm; C Y Chen; A B Shyu; M Müller; M Gaestel; K Resch; H Holtmann
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

10.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

View more
  27 in total

1.  Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.

Authors:  Raymond T Chung; Michael Gale; Stephen J Polyak; Stanley M Lemon; T Jake Liang; Jay H Hoofnagle
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

2.  Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation.

Authors:  Shawn Monique Castro; Deepthi Kolli; Antonieta Guerrero-Plata; Roberto P Garofalo; Antonella Casola
Journal:  Toxicol Sci       Date:  2008-08-22       Impact factor: 4.849

3.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

4.  Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.

Authors:  Kui Li; Nan L Li; Dahai Wei; Susan R Pfeffer; Meiyun Fan; Lawrence M Pfeffer
Journal:  Hepatology       Date:  2012-01-30       Impact factor: 17.425

5.  Viral manipulation of host mRNA decay.

Authors:  Liang Guo; Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Future Virol       Date:  2018-02-23       Impact factor: 1.831

Review 6.  Interaction of hepatitis C virus with the type I interferon system.

Authors:  Friedemann Weber
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

7.  Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.

Authors:  Karla J Helbig; Andrew Ruszkiewicz; Robert E Lanford; Mark D Berzsenyi; Hugh A Harley; Shaun R McColl; Michael R Beard
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

Review 8.  Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.

Authors:  Patrick Arbuthnot; Liam-Jed Thompson
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.

Authors:  Hironori Nishitsuji; Kenji Funami; Yuko Shimizu; Saneyuki Ujino; Kazuo Sugiyama; Tsukasa Seya; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.

Authors:  Michael A Joyce; Kathie-Anne Walters; Sue-Ellen Lamb; Mathew M Yeh; Lin-Fu Zhu; Norman Kneteman; Jason S Doyle; Michael G Katze; D Lorne Tyrrell
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.